Cargando…

Launch of a Nationwide Hepatitis C Elimination Program — Georgia, April 2015

Detalles Bibliográficos
Autores principales:	Mitruka, Kiren, Tsertsvadze, Tengiz, Butsashvili, Maia, Gamkrelidze, Amiran, Sabelashvili, Paata, Adamia, Ekaterine, Chokheli, Mari, Drobeniuc, Jan, Hagan, Liesl, Harris, Aaron M., Jiqia, Tea, Kasradze, Ana, Ko, Stephen, Qerashvili, Vakhtang, Sharvadze, Lali, Tskhomelidze, Irina, Kvaratskhelia, Valeri, Morgan, Juliette, Ward, John W., Averhoff, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	U.S. Centers for Disease Control 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584859/ https://www.ncbi.nlm.nih.gov/pubmed/26203628

Ejemplares similares

Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia
por: Tsertsvadze, Tengiz, et al.
Publicado: (2020)

The Role of Screening and Treatment in National Progress Toward Hepatitis C Elimination — Georgia, 2015–2016
por: Nasrullah, Muazzam, et al.
Publicado: (2017)

An evaluation of the hepatitis C testing, care and treatment program in the country of Georgia’s corrections system, December 2013 – April 2015
por: Harris, Aaron M., et al.
Publicado: (2019)

Progress in Testing for and Treatment of Hepatitis C Virus Infection Among Persons Who Inject Drugs — Georgia, 2018
por: Stvilia, Ketevan, et al.
Publicado: (2019)

The prevalence of hyperglycemia and its impact on mortality among people living with HIV in Georgia
por: Borkowska, Tea, et al.
Publicado: (2022)

Risk factors and genotype distribution of hepatitis C virus in Georgia: A nationwide population-based survey
por: Baliashvili, Davit, et al.
Publicado: (2022)

Toward reaching hepatitis B goals: hepatitis B epidemiology and the impact of two decades of vaccination, Georgia, 2021
por: Khetsuriani, Nino, et al.
Publicado: (2023)

Interim effect evaluation of the hepatitis C elimination programme in Georgia: a modelling study
por: Walker, Josephine G, et al.
Publicado: (2019)

Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination
por: Hagan, Liesl M., et al.
Publicado: (2019)

Hepatitis C care cascade among patients with and without tuberculosis: Nationwide observational cohort study in the country of Georgia, 2015–2020
por: Baliashvili, Davit, et al.
Publicado: (2023)

Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia
por: Chkhartishvili, Nikoloz, et al.
Publicado: (2014)

Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: A prospective three‐arm study
por: Shilton, Sonjelle, et al.
Publicado: (2022)

The natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia
por: Tsertsvadze, Tengiz, et al.
Publicado: (2016)

Retreatment of Chronic Hepatitis C Infection: Real-World Regimens and Outcomes From National Treatment Programs in Three Low- and Middle-Income Countries
por: Boeke, Caroline E, et al.
Publicado: (2021)

High sustained viral response among HCV genotype 3 patients with advanced liver fibrosis: real-world data of HCV elimination program in Georgia
por: Butsashvili, Maia, et al.
Publicado: (2020)

Late presentation of HIV infection in the country of Georgia: 2012-2015
por: Chkhartishvili, Nikoloz, et al.
Publicado: (2017)

Multistakeholder perspectives on the strengthening and embedding of mandatory continuing medical education in Georgia: a qualitative study
por: Ruadze, Ekaterine, et al.
Publicado: (2021)

Evaluation of multiple measures of antiretroviral adherence in the Eastern European country of Georgia
por: Chkhartishvili, Nikoloz, et al.
Publicado: (2014)

Outcomes of Universal Access to Antiretroviral Therapy (ART) in Georgia
por: Tsertsvadze, Tengiz, et al.
Publicado: (2011)

Insights from a national survey in 2021 and from modelling on progress towards hepatitis C virus elimination in the country of Georgia since 2015
por: Walker, Josephine G., et al.
Publicado: (2023)

Cascade of care among HIV patients diagnosed in 2013 in Georgia: Risk factors for late diagnosis and attrition from HIV care
por: Ruadze, Ekaterine, et al.
Publicado: (2017)

Identifying Sources of Lead Exposure for Children in the Republic of Georgia, with Lead Isotope Ratios
por: Leonardi, Giovanni S., et al.
Publicado: (2023)

Treatment Duration for Patients with Drug-Resistant Tuberculosis, United States
por: Winston, Carla A., et al.
Publicado: (2012)

Cruise Ship Travel
por: Mitruka, Kiren, et al.
Publicado: (2008)

Rethinking the COVID-19 Pandemic: Back to Public Health
por: Collins, Téa, et al.
Publicado: (2020)

Assessment of quality of life in people living with HIV in Georgia
por: Karkashadze, Ekaterine, et al.
Publicado: (2016)

Hantavirus Infection in the Republic of Georgia
por: Kuchuloria, Tinatin, et al.
Publicado: (2009)

Procalcitonin as a marker of bacterial sepsis in immunocompromised patients
por: Gatserelia, Lana, et al.
Publicado: (2012)

Barriers of linkage to HCV viremia testing among people who inject drugs in Georgia
por: Butsashvili, Maia, et al.
Publicado: (2022)

Crimean-Congo Hemorrhagic Fever in Man, Republic of Georgia, 2009
por: Zakhashvili, Khatuna, et al.
Publicado: (2010)

Reduction in Blood Lead Concentration in Children across the Republic of Georgia following Interventions to Address Widespread Exceedance of Reference Value in 2019
por: Ruadze, Ekaterine, et al.
Publicado: (2021)

Tuberculosis Outbreak Investigations in the United States, 2002–2008
por: Mitruka, Kiren, et al.
Publicado: (2011)

Disease Surveillance in Georgia: Benefits of International Cooperation
por: Bakanidze, Lela, et al.
Publicado: (2008)

Evidence of Extensive Circulation of Yersinia enterocolitica in Rodents and Shrews in Natural Habitats from Retrospective and Perspective Studies in South Caucasus
por: Imnadze, Tata, et al.
Publicado: (2021)

Cutaneous Anthrax surveillance by Person, Place, and Time in Georgia (2008-2013)
por: Kasradze, Anna, et al.
Publicado: (2015)

Rates and risk factors for human cutaneous anthrax in the country of Georgia: National surveillance data, 2008–2015
por: Kasradze, Ana, et al.
Publicado: (2018)

Correction: Rates and risk factors for human cutaneous anthrax in the country of Georgia: National surveillance data, 2008–2015
por: Kasradze, Ana, et al.
Publicado: (2018)

Hepatitis C core antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysis
por: Sadeghimehr, Maryam, et al.
Publicado: (2021)

Spread of Clostridium botulinum in the soils of Georgia
por: Zhorzholiani, Ekaterine, et al.
Publicado: (2017)

Launched
Publicado: (1885)

Cannot write session to /tmp/vufind_sessions/sess_ebuiln5ol5ua1c4kjt3h88scps